This site is intended for US residents 18 years of age or older.
.png?h=492&iar=0&w=1548&hash=6F8A1EE9C2EDA7E12DE446730D1C483B){kind=logo}
This site is intended for US residents 18 years of age or older.
Lung problems that may be severe, life-threatening, or that may lead to death can occur with DATROWAY. If you develop lung problems, your doctor may treat you with corticosteroid medicines. Tell your care team right away if you have any of the following: cough, trouble breathing or shortness of breath, fever, or other new or worsening breathing symptoms such as chest tightness or wheezing.
Eye problems are common with DATROWAY and can also be severe. Tell your care team right away if you develop any new or worsening eye problems during treatment with DATROWAY, including dry eyes, eye pain, eye redness, eye swelling, eye irritation, increased tears, feeling like something is in your eyes, discharge from your eyes, eye crusting, sensitivity to light, blurred vision, or vision changes.
Mouth ulcers and sores are common with DATROWAY and can also be severe. Tell your care team right away if you develop mouth pain, swelling, redness, ulcers, or sores during treatment with DATROWAY.
DATROWAY may cause harm to your unborn baby. Tell your care team right away if you become pregnant or think you might be pregnant during treatment with DATROWAY.
This is not a complete list of symptoms for DATROWAY-associated side effects or all possible side effects of DATROWAY. Call your doctor for medical advice about symptoms or side effects. You may report side effects to Daiichi Sankyo at 1-877-437-7763 or to FDA at 1-800-FDA-1088.
The most common side effects of DATROWAY when used in adults with epidermal growth factor receptor (EGFR) mutated non-small cell lung cancer (NSCLC) include mouth ulcers and sores, nausea, hair loss, tiredness, decreased red blood cell counts, decreased white blood cell counts, constipation, increased blood levels of calcium, increased blood levels of liver enzymes, increased levels of enzyme called lactate dehydrogenase in the blood, muscle and joint pain, decreased appetite, and rash.
The majority of side effects in people who received DATROWAY for locally advanced or metastatic EGFR-mutated NSCLC were mild or moderate in severity. Mild side effects may not affect your daily activities, and medical intervention may not be needed. Moderate side effects may affect your daily activities and may require some medical intervention. Severe side effects usually require medical intervention and may have serious or life-threatening consequences.
EGFR=epidermal growth factor receptor.
With any treatment, side effects are possible, so it’s important to plan ahead and decide with your care team the best course of action that may help prevent or treat certain side effects. After learning about the side effects seen in the clinical trials, review the Managing Side Effects page so that you and your care team can prepare ahead of time for possible side effects.
Battling cancer requires courage, resilience, and the right information to help keep you moving forward.
About 8% of people with EGFR-mutated locally advanced or metastatic NSCLC receiving DATROWAY discontinued treatment due to side effects. Refer to the Managing Side Effects page for more information.
Consult your care team and refer to the Managing Side Effects page for more information on how you can help treat or possibly prevent certain side effects.
Serious side effects occurred in 26% of the people with EGFR-mutated locally advanced or metastatic NSCLC who were treated with DATROWAY.
